Nutrient-sensing pathway (null)

The term "Nutrient-sensing pathway" does not refer to a single molecule, receptor, or protein but rather encompasses multiple interconnected cellular signaling networks that detect and respond to changes in nutrient availability. These include key regulators such as mechanistic target of rapamycin complex 1 (mTORC1), AMP–activated protein kinase (AMPK), insulin receptor/insulin-like growth factor 1 receptor pathways, sirtuins/NAD+ sensors, and others. These systems collectively allow cells and organisms to adapt their metabolism according to nutrient status by modulating processes like anabolism during abundance and catabolism during scarcity. Dysregulation of these pathways is implicated in various diseases including cancer, metabolic syndrome/diabetes, obesity-related disorders, aging-associated pathologies, and stem cell dysfunction. While some drugs can modulate individual nodes within these networks—such as rapamycin inhibiting mTOR—the term itself is too broad for direct therapeutic targeting without specifying the particular molecular component involved[1][2][3][4][5]. Summary: "Nutrient-sensing pathway" is not itself a canonical drug target but describes an essential set of biological processes involving several well-defined molecular targets. For structured data purposes it should be flagged as incorrect/not sufficiently specific for use as an individual therapeutic target entry.

Other names

Nutrient sensingNutrient-sensing mechanismsNutrient and energy sensing pathways

null (see above; mechanisms depend on the specific pathway component targeted—e.g., mTOR inhibitors block anabolic signaling in response to amino acids)